About Omega Diagnostics Group Plc (LON:ODX)
Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Diagnostic & Testing Substances
- Sub-Industry: N/A
- Symbol: LON:ODX
- CUSIP: N/A
- Web: www.omegadiagnostics.com/
- Market Cap: £23.65 million
- Outstanding Shares: 108,745,000
- 50 Day Moving Avg: GBX 22.54
- 200 Day Moving Avg: GBX 21.89
- 52 Week Range: GBX 15.94 - GBX 28.01
Sales & Book Value:
- Trailing P/E Ratio: 31.33
- P/E Growth: 0.00
- Annual Revenue: £14.25 million
- Price / Sales: 1.66
- Book Value: GBX 0.20 per share
- Price / Book: 1.09
- EBITDA: £1.29 million
- Net Margins: 4.46%
- Return on Equity: 3.10%
- Return on Assets: 2.60%
- Average Volume: 94,354 shs.
Frequently Asked Questions for Omega Diagnostics Group Plc (LON:ODX)
What is Omega Diagnostics Group Plc's stock symbol?
Omega Diagnostics Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "ODX."
Where is Omega Diagnostics Group Plc's stock going? Where will Omega Diagnostics Group Plc's stock price be in 2017?
0 brokers have issued 1-year target prices for Omega Diagnostics Group Plc's shares. Their forecasts range from GBX 30 to GBX 30. On average, they expect Omega Diagnostics Group Plc's share price to reach GBX 30 in the next year. View Analyst Ratings for Omega Diagnostics Group Plc.
Who are some of Omega Diagnostics Group Plc's key competitors?
Some companies that are related to Omega Diagnostics Group Plc include Amryt Pharma PLC (AMYT), Abzena PLC (ABZA), Concordia International Corp (CXR), Scancell Holdings Plc (SCLP), CorMedix (CRMD), Oncobiologics (ONS), Redx Pharma PLC (REDX), Cambridge Cognition Holdings PLC (COG), ANGLE plc (AGL), Can Fite Biopharma Ltd (CANF), Futura Medical plc. (FUM), Midatech Pharma PLC (MTPH), Advanced Oncotherapy PLC (AVO), Venture Life Group PLC (VLG), LiDCO Group plc (LID), Scientific Digital Imaging plc (SDI), Biopharmx Corp (BPMX) and Biopharmx Corp (BPMX).
Who are Omega Diagnostics Group Plc's key executives?
Omega Diagnostics Group Plc's management team includes the folowing people:
- Andrew Shepherd, Chief Executive, Managing Director, Executive Director
- Kieron Harbinson, Group Finance Director, Company Secretary, Executive Director
- Colin King, Chief Operating Officer, Director
- Iain Logan, Group Financial Controller
- Jag Grewal, Group Sales and Marketing Director, Executive Director
- Karsten Brenzke, Site Manager of Omega Diagnostics GmbH
- Mike Gordon, Group Operations Director
- Prashant Maniar, Managing Director of Omega Dx (Asia) Pvt Limited
- Edward Valente, Group Research and Development Director
- Jamie Yexley, Site Manager of Genesis Diagnostics Limited and Cambridge Nutritional Sciences Limited
How do I buy Omega Diagnostics Group Plc stock?
Shares of Omega Diagnostics Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Omega Diagnostics Group Plc's stock price today?
MarketBeat Community Rating for Omega Diagnostics Group Plc (LON ODX)MarketBeat's community ratings are surveys of what our community members think about Omega Diagnostics Group Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Omega Diagnostics Group Plc stock can currently be purchased for approximately GBX 21.75.
Consensus Ratings for Omega Diagnostics Group Plc (LON:ODX) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||GBX 30|Consensus Price Target History for Omega Diagnostics Group Plc (LON:ODX)
Analysts' Ratings History for Omega Diagnostics Group Plc (LON:ODX)
(Data available from 10/20/2015 forward)
|10/16/2017||FinnCap||Reiterated Rating||Corporate||GBX 30|
Earnings History for Omega Diagnostics Group Plc (LON:ODX)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Omega Diagnostics Group Plc (LON:ODX)
Current Year EPS Consensus Estimate: $0.84 EPS
Dividend History for Omega Diagnostics Group Plc (LON:ODX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Omega Diagnostics Group Plc (LON:ODX)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Omega Diagnostics Group Plc (LON:ODX)
Latest Headlines for Omega Diagnostics Group Plc (LON:ODX)
Omega Diagnostics Group Plc (ODX) Chart for Friday, October, 20, 2017